Toxicity and human health risk of hair dyes

Food and Chemical Toxicology

Volumn 42, Issue 4, 2004, Pages 517-543

  Nohynek, Gerhard J ^a   Fautz, Rolf ^b   Benech Kieffer, Florence ^c   Toutain, Herve ^a  

^a L ORÉAL RECHERCHE   (France)

^b KAO GERMANY GMBH   (Germany)

^c L'Oreal Rech Cutaneous B ^*  (France)

Author keywords

2 Hydroxy 1,4 naphthoquinone; Aromatic amines; Carcinogenicity; Genetic toxicity; Hair dyes; Lawsone; Margin of safety; p Phenylenediamine; p Toluenediamine; para Aminophenol; para phenylenediamine; para toluenediamine; Percutaneous absorption; PPD; PTD; Resorcinol

Indexed keywords

2,5 DIAMINOTOLUENE; 4 AMINOPHENOL; HAIR DYE; LAWSONE; PHENYLENEDIAMINE;

ACUTE TOXICITY; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER INCIDENCE; CANCER RISK; CONTACT ALLERGY; CONTACT SENSITIZATION; DISEASE ASSOCIATION; FOOD AND DRUG ADMINISTRATION; GENOTOXICITY; HUMAN; INDUSTRIALIZATION; MAXIMUM TOLERATED DOSE; OCCUPATIONAL EXPOSURE; REVIEW; RISK ASSESSMENT;

ANIMALS; BEAUTY CULTURE; CELLS, CULTURED; CONSUMER PRODUCT SAFETY; HAIR DYES; HUMANS; INTERNATIONAL COOPERATION; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; TOXICITY TESTS;

RODENTIA;

EID: 1542376198     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2003.11.003     Document Type: Review

References (154)

1. Altekruse S.F., Henley S.J., Thun M.J. Death from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study. Cancer Causes and Control. 10:1999;617-625.
2. Ames B.N., Kammen H.O., Yamasaki E. Hair dyes are mutagenic. Identification of a variety of mutagenic ingredients Proceedings of the National Academy of Sciences USA. 72:1975;2423-2427.
3. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP. Mutation Research. 257:1991;229-306.
4. Ashby J., Waters M.D., Preston J., Adler I.D., Douglas G.R., Fielder R., Shelby M.D., Anderson D., Sofuni T., Gopalan H.N.B., Becking G., Sonich-Mullin C. IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens. Mutation Research. 352:1996;153-157.
5. 14C)-toluenediamine Absorption Through Hair-bearing Scalp, Disposition and Elimination in Adult Healthy Subjects Following Application of Two Formulations Containing p-Toluenediamine. 1981;Simbec Research Laboratories, South Wales, UK. (unpublished).
6. Babish J.G., Scarlett J.M., Voekler S., Gutemann W.H., Lisk D.J. Urinary mutagens in cosmetologists and dental personnel. Journal of Toxicology and Environmental Health. 34:1991;197-206.
7. Bartsch H., Malavelle C., Friesen M., Kadlubar F.F., Vineis G. Black (air-cured) and blond (flue-cured) tobacco cancer risk IV. molecular dosimetry studies implicated aromatic amines as bladder carcinogens European Journal of Cancer. 29A(8):1993;1199-1207.
8. Beck H., Bracher M., Faller C., Hofer H. Comparison of in vitro and in vivo skin permeation of hair dyes. Scott R.C., Guy R.H., Hadgraft J. Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, Vol. 2. 1991;441-450 IBC Technical Series, London.
9. Beck H., Bracher M., Bartnik F.G. Percutaneous absorption of hair dyes. an inter-laboratory comparison of in vivo and in vitro data with rat and pig In Vitro Toxicology. 7(4):1994;305-312.
10. 14C-Mexoryl SX in human volunteers. Skin Pharmacology Applied Skin Physiology. 16:2003;343-355.
11. Benning V., Brault D., Duvinage C., Thybaud V., Melcion C. Validation of the in vivo CD1 Mouse Splenocyte Micronucleus Test. Mutagenesis. 9(3):1994;199-204.
12. BGVV, 2002. Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin. Strategies for Genotoxicity Testing of Substances. An Overview. Berlin, Germany, August 2002. Available at: http://www.bgvv.de.
13. BKH BKH Consulting and Engineers and TNO Nutrition and Food Research. Towards establishment of a priority list of substances for further evaluation of their role in endocrine disruption. 2000;TNO, Delft, The Netherlands.
14. Bracher M., Faller C., Grötsch W., Marshall R., Spengler J. Studies on the potential mutagenicity of p-phenylenediamine in oxidative hair dye mixtures. Mutation Research. 241:1990;313-323.
15. Bronaugh R.L., Maibach H.I. Percutaneous absorption of nitroaromatic compounds. in vivo and in vitro studies in the human and monkey Journal of Investigative Dermatology. 84:1985;180-183.
16. Bukowski J.A., Schnatter A.R., Korn L. Using epidemiological studies to check the consistency of the cancer risks predicted by high-dose animal experiments. a methodological review Risk Analysis. 21(4):2001;601-611.
17. Bull G.M., Fraser T.R. Myxoedema from resorcinol ointment applied to leg ulcers. Lancet. 6:1950;851-852.
18. Burnett C., Lanman B., Giovacchini R., Wolcott G., Scala R., Keplinger M. Long-term toxicity studies on oxidation hair dyes. Food and Cosmetic Toxicology. 13:1975;353-357.
19. Burnett C.M., Fuchs C.M., Corbett J.F. Mutagenicity studies on urine concentrates from female users of dark hair color products. Food and Chemical Toxicology. 2:1979;283-293.
20. Burnett C., Jacobs M.M., Seppala A., Shubik P. Evaluation of the toxicity and carcinogenicity of hair dyes. Journal of Toxicology and Environmental Health. 6:1980;247-257.
21. Burnett C., Loehr R., Corbett J. Heritable translocation study on two hair dye formulations. Fundamental Applied Toxicology. 1:1981;325-328.
22. Burnett C., Fuchs C., Corbett J., Menkart J. The effect of dimethylsulfoxide on the mutagenicity of the hair dye p-phenylenediamine. Mutation Research. 103:1982;1-4.
23. Burnett C.M., Corbett J.F. Failure of short-term in vitro mutagenicity tests to predict the animal carcinogenicity of hair dyes. Food and Chemical Toxicology. 25(9):1987;703-707.
24. Burnett C.M., Goldenthal E.J. Multigeneration reproduction and carcinogenicity studies in Sprague Dawley rats exposed topically to oxidative hair coloring formulations containing p-phenylenediamine. Food and Chemical Toxicology. 26:1988;467-474.
25. Burnett C.M., Re T.A., Rodriguez S., Loehr R.F., Dressler W.E. The toxicity of p-aminophenol in the Sprague-Dawley rat. Effects on growth, reproduction and foetal development Food and Chemical Toxicology. 27(10):1989;691-698.
26. Cantox Inc Resorcinol: Toxicology Review and Risk Assessment with Emphasis on Thyroidal Effects. 2000;Cantox Health Sciences International, New Jersey. August 16, 2000 (unpublished).
27. Chiang T.A., Pei-Fen W., Ying L.S., Wang L.F., Ko Y.C. Mutagenicity and aromatic amine content of fumes from heated cooking oils produced in Taiwan. Food and Chemical Toxicology. 37(2-3):1999;125-134.
28. CIR Estrin, N.F. The Cosmetic Ingredient Review. Cutis. 21(1):1978;35-41.
29. CIR Final report on the safety assessment of 2-methylresorcinol and resorcinol. Journal of the American College of Toxicology. 5(3):1986;167-203.
30. CIR, 2003. Cosmetic Ingredient Review, general information: How Does the CIR Work? Accessible at the CIR web site: http://www.cir-safety.org.
31. Claude J., Kunze E., Frenzel-Beyme R., Paczkowski K., Schneider J., Schubert H. Life-style and occupational risk factors in cancer of the lower urinary tract. American Journal of Epidemiology. 124:1986;578-589.
32. Cleary G.W. Transdermal delivery systems: a medical rationale. Shah V.P., Maibach H.I. Topical Drug Bioavailability, Bioequivalence and Penetration. 1993;17-68 Plenum Press, New York, US.
33. Clement Associates, 1978, US Food and Drug Administration, Docket 77-0353, Appendix 100 to CTFA comments.
34. Colditz G.A. Hair dye and cancer. reassuring evidence of no association Journal of the National Cancer Institute. 86:1994;164-165.
35. Colditz G.A., Coakley E. Weight, weight gain, activity, and major illnesses. the Nurse's Health Study International Journal of Sports Medicine. 18(Suppl. 3):1997;162-170.
36. COM Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM). Guidance on a Strategy for Testing of Chemicals for Mutagenicity UK. 2000;Department of Health, London, UK.
37. Contrera J.F., Jacobs A.C., Prasanna H.R., Mehta M., Schmidt W.J., De George J. A systemic exposure-based alternative to the maximum tolerated dose for carcinogenicity studies of human therapeutics. Journal of the American College of Toxicology. 14(1):1995;110.
38. Corbett J.F. An historical review of the use of dye precursors in the formulation of commercial oxidation hair dyes. Dyes and Pigments. 41:1999;127-136.
39. Corbett J.F., Sharma R.K., Dressler W.E. Cosmetic toxicology. Marquart H., Schäfer S.G., McClellan R., Welsch F. Toxicology. 1999;899-910 Academic Press, San Diego, US.
40. Cordle F., Thompson G.E. An epidemiologic assessment of hair dye use. Regulatory Toxicology and Pharmacology. 1:1981;388-400.
41. Crebelli R., Conti L., Carere A., Zito R. Mutagenicity of commercial p-phenylenediamine and of an oxidation mixture of p-phenylenediamine and resorcinol in Salmonella typhimurium TA98. Food and Chemical Toxicology. 19:1981;79-84.
42. CSTEE, 2001. EU Scientific Committee on Toxicity, Ecotoxicity and the Environment (2001). Hydrogen peroxide. Human health effects. Opinion of the 26th CSTEE Meeting, 11 September, 2001. Available at http://europa.eu.int/comm./ food/fs/sc/sct/index_en.hmtl.
43. Czene K., Tikkaja S., Hemminki K. Cancer risk in hairdressers. assessment of carcinogenicity of hair dyes and gels International Journal of Cancer. 105:2003;108-112.
44. Davis M.G., Vella-Briffa D., Greaves M.W. Systemic toxicity of topically applied salicylic acid. British Medical Journal. 1979;661-668.
45. DeGroot A.C. Fatal attractiveness. the shady side of cosmetics Clinics in Dermatology. 16:1998;167-179.
46. Dethloff L.A., Chang T., Courtney C.L. Toxicological comparison of a muscarinic agonist given to rats by gavage or in the diet. Food and Chemical Toxicology. 34:1996;407-422.
47. Donach I., Logothetopoulos J. The goitrogenic action of resorcinol in rats. British Journal of Experimental Pathology. 345:1953;146-151.
48. Dos Santos Silva, I., 1999. Interpretation of epidemiological studies. In: Cancer Epidemiology: Principles and Methods, International Agency for Research of Cancer, Lyon, France, pp. 277-303.
49. Dressler W. Hair dye absorption. Bronough R.L., Maibach H.I. Percutaneous Absorption. Chapter 40. Vol. 97 of Drugs and the Pharmaceutical Sciences. 1999;685-716 Marcel Dekker, New York/Basel.
50. ECB, 2003. European Chemicals Bureau, Institute or Health and Consumer Protection. Technical guidance document on risk assessment. Part I., 127. Ispra, Italy, April 2003.
51. Engelhardt, G., Schwind, K.R., Mussler, B. The testing in the Syrian hamster embryo (SHE) cell transformation assay for assessment of carcinogenic potential. Toxicology In Vitro (in press).
52. EU, 1976. European Union. Cosmetic Directive 76/768, 29.7.1976, 6 modifications and 26 adaptations.
53. Farmer P.B. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment. ILSI/HESI Research Program on alternative cancer models: results of Syrian hamster cell transformation assay. Toxicological Pathology. 30(4):2002;536-538.
54. Fassina G., Abbondandolo A., Mariani L., Taningher M., Parodi S. Mutagenicity in V 79 cells does not correlate with carcinogenicity in small rodents for 12 aromatic amines. Journal of Toxicology and Environmental Health. 29(1):1990;109-130.
55. Fukushima, S., Mural, T., 1999. Calculi, precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesis in rats and mice. IARC Scientific Publication No. 147, pp. 159-174, International Agency for Research of Cancer, Lyon, France.
56. Gagliardi L., Ambroso M., Mavro J., Furno F., Discalzi G. Exposure to paraphenylenediamine in hairdressing parlors. International Journal of Cosmetic Science. 14(1):1992;19-31.
57. Gago-Dominguez M., Castelao J.E., Yuan J.M., Yu M.C., Ross R.K. Use of permanent hair dyes and bladder cancer risk. International Journal of Cancer. 91:2001;575-579.
58. Gago-Dominguez M., Bell D.A., Watson M.A., Jian-Min Y., Castelao J.E., Hein D.W., Chan K.K., Coetzee G.A., Ross R.K., Yu M.C. Permanent hair dyes and bladder cancer. risk modification by cytochrome P450A2 and N-Acetyltransferase 1 and 2 Carcinogenesis. 24(3):2003;483-489.
59. Gaylor D.W., Gold L.S. Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose of rodent bioassays. Regulatory Toxicology and Pharmacology. 22:1995;57-63.
60. Giles A.L., Chung C.W., Kommineni C. Dermal carcinogenicity study by mouse skin painting with 2,4-toluenendiamine alone or in representative hair dye formulations. Journal of Toxicology and Environmental Health. 1:1976;440-443.
61. Goetz N., Masserre P., Bore P., Kalopissis G. Percutaneous absorption of p-phenylene-diamine during an actual hair dyeing process. International Journal of Cosmetic Science. 10:1988;63-73.
62. Golka K., Prior V., Blaszkewicz M., Bolt H.M. The enhanced bladder cancer susceptibility of NATY2 slow acetylators towards aromatic amines. a review considering ethnic differences Toxicology Letters. 128:2002;229-241.
63. Goossens A., Merckx L. L'allergie de contact aux cosmetiques. Allergie et Immunologie. 24(10):1997;300-303.
64. Green J., Banks E., Berrington A., Darby S., Deo H., Newton R. N-acetyltransferase 2 and bladder cancer. an overview and consideration of the evidence for gene-environment interaction British Journal of Cancer. 83(3):2000;412-417.
65. Hall, B. Hair dyes: history of use, sensitisation hazard, exposure, risk management and epidemiology of contact sensitivity. In: Bouillon, C, (Ed.). The Science of Hair Care, second ed. Marcel Dekker Inc., New York and Basel (in press).
66. Hartge P., Hoover R., Altman R., Austin D.F., Cantor K.P., Child M.A., Key C.R., Mason T.J., Marret L.D., Myers M.H., Narayana A.S., Silverman D.T., Sullivan J.W., Swanson G.M., Thomas D.B., West D.W. Use of hair dyes and risk of bladder cancer. Cancer Research. 42:1982;4784-4787.
67. Haseman J.K., Rao G.N. Effects of corn oil, time-related changes, and inter-laboratory variability on tumor occurrence in control Fischer 344 rats. Toxicologic Patholology. 20(1):1992;52-60.
68. Helzlsouer, K., Rollison, D., Pinney, S. Association between hair dye use and health outcomes: Review of the literature published since 1992. Expert report submitted to the US Cosmetic Ingredient Review, August 14, 2003. Journal of the American College of Toxicology (submitted for publication).
69. Henley S.J., Thun M.J. Use of permanent hair dyes and bladder cancer risk. International Journal of Cancer. 94:2001;903-904.
70. Hennekens, C.H., Rosner, B., Belanger, C., Speizer, F.E., Bian, C.J., 1979. Use of permanent hair dyes and cancer among registered nurses. Lancet, 1, June 30, 1979, 1390-1393.
71. Hofer H., Bornatowicz N., Reindl E. Analysis of human chromosomes after repeated hair dyeing. Food and Chemical Toxicology. 21(6):1983;785-789.
72. Howe G.R., Burch J.D., Miller A.B., Cook G.M., Esteve J., Morrison B., Gordon P., Chambers L.W., Fodor G., Winsor G.M. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. Journal of the National Cancer Institute. 64:1980;701-713.
73. Hueber-Becker, F., Nohynek, G.J., Meuling, W. L., Leclaire, J., Benech-Kiefer, F., 2003. Percutaneous absorption of a p-phenylenediamine- containing hair dye in human volunteers: comparison with in vitro data on human dermatomed skin and pig ear skin. Journal of Food and Chemical Toxicology (submitted for publication).
74. IARC International Agency for the Research of Cancer, World Health Organisation. Occupational exposure of hairdressers and barbers and personal use of hair colorants. Some hair dyes, cosmetic colorants, industrial dyestuffs and aromatic amines. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Volume 57. 1993;World Health Organisation, Geneva, Switzerland.
75. ICH International Conference on Harmonisation. ICH Topic S 3 A. Toxicokinetics: A Guidance for Assessing Systemic Exposure in Toxicology Studies. 1995;ICH technical coordination, London, UK.
76. ICH International Conference on Harmonisation. ICH Topic M 3. Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals. 1997;ICH technical coordination, London, UK.
77. Industrial Bio-test Laboratories, 1971. Data Sheet No. 21-3/71, 1971. Results (abstract) listed in ToxNet, http://toxnet.nlm.nih.gov/.
78. Johns L.E., Houlston R.S. N-acetyl transferase-2 and bladder cancer risk. a meta-analysis Environmental and Molecular Mutagenesis. 36:2000;221-227.
79. Kalopissis G. Toxicology of hair dyes. Zviak C. The Science of Hair Care, First Ed. 1986;287-308 Marcel Dekker, New York.
80. Kawakubo Y., Yamazoe Y., Kato R., Nishikawa T. High capacity of human skin for N-acetylation of arylamines. Skin Pharmacology. 3:1990;180-185.
81. Kawakubo Y., Merk H.F., Al Masaoudi T., Sieben S., Bloemeke B. N-acetylation of paraphenylenediamine in human skin and keratinocytes. Journal of Pharmacology and Experimental Therapeutics. 292(1):2000;150-155.
82. Kerckaert G.A., LeBoeuf R.A., Isfort R.J. Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/nitroaromatic amine compounds. Toxicological Sciences. 41:1998;189-197.
83. Kinkel H.J., Holzmann S. Study of long-term toxicity and carcinogenicity of hair dyes (oxidising dyes) in rats. Food and Cosmetic Toxicology. 11:1973;641-648.
84. Kirkland D.J., Lawler S.D., Venitt S. Chromosomal damage and hair dyes. The Lancet, July. 15:1978;124-128.
85. Kirkland D.J., Honeycombe J.R., Lawler S.D., Vernitt S., Crofton-Sleigh C. Sister chromatid exchanges before and after hair dyeing. Mutation Research. 90:1981;279-286.
86. Kirkland D.J., Dresp J.H., Marshall R.R., Baumeister M., Gerloff C., Gocke E. Normal chromosome aberration frequencies in peripheral lymphocytes of human volunteers exposed to a maximal daily dose of paracetamol in a double blind trial. Mutation Research. 279:1992;181-194.
87. Kirkland D.J., Marzin D. An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient of henna. Mutation Research. 537(2):2003;183-199.
88. Krause W., Reissmann F., Schunack W., Schrödel C. Comparative pharmacokinetics of abecarnil in rat following single and multiple intragastric treatments and continuous administration in the diet. Drug Metabolism and Disposition. 19(1):1991;29-35.
89. La Vecchia C., Tavani A. Epidemiological evidence on hair dyes and the risk of bladder cancer in humans. European Journal of Cancer Prevention. 4:1995;31-43.
90. La Vecchia C., Negri E. Nutrition and bladder cancer. Cancer Causes and Control. 7:1996;95-100.
91. LaVecchia C., Airodi, L., 1999. Human bladder cancer: epidemiological, pathological and mechanistic aspects. IARC Scientific Publication No. 147, 139-157, International Agency for Research of Cancer, Lyon, France.
92. La Vecchia C., Tavani A. Hair dyes and bladder cancer. an update European Journal of Cancer Prevention. 10:2001;205-208.
93. LeBoeuf R.A., Kerckaert G.A. Enhanced morphological transformation of early passage Syrian hamster embryo cells cultured in medium with reduced bicarbonate concentration and pH. Carcinogenesis. 8:1987;689-697.
94. LeBoeuf R.A., Kerckaert G.A., Aardema M.J., Gibson D.P., Brauninger R., Isfort R.J. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutation Research. 356:1996;85-127.
95. Loprieno N. Regulation. Bran R., Maibach H. Cosmetic Dermatology, Chapter 3: Toxicology of Cosmetic Ingredients. 1994;37-46 Martin Dunitz, London, UK.
96. Lynch B.S., Daniels J., Nestmann E., Wilson R., Munro I., Sharma R., Grabarz R., Dreassler W. Assessment of the reproductive risks posed to hairdressers and consumers exposed to dye products containing p-aminophenol. The Toxicologist. 42(1S):1998;225.
97. Lynch B.S., Delzell E.S., Bechtel D.H. Toxicology review and risk assessment of resorcinol. thyroid effects Regulatory Toxicology and Pharmacology. 36:2002;198-210.
98. Maibach H.I., Wolfram L.J. Percutaneous penetration of hair dyes. Journal of the Society of Cosmetic Chemists. 32:1981;223-229.
99. Marks T.A., Gumpta B.N., Ledoux T.A., Staples R.E. Teratogenic evaluation of 2-nitro-o-phenylenediamine, 4-nitro-phenylenediamine and 2,5-toluenediaminesulfate in the mouse. Teratology. 24:1981;253-256.
100. Maouad M., Fleischer A.B., Sherertz E.F., Feldman S.R. Significance-prevalence index number. a re-interpretation and enhancement of data from the North American Contact Dermatitis Group Journal of the American Academy of Dermatology. 41(4):1999;573-576.
101. McDonald A.D.et al. Prematurity and work in pregnancy. British Journal of Industrial Medicine. 45:1988;56-62.
102. 14C]-PPD-containing hair dye to human volunteers. Toxicology Letters. 144(Suppl. 1):2003;160.
103. Monnais C. Haarfarbänderungsmittel. Umbach W. Kosmetik - Entwickung, Herstellung und Anwendung kosmetischer Mittel, second ed. 1995;287-307 Georg Thieme Verlag, Stuttgart, Germany.
104. NCI, 2003. US National Cancer Institute. Surveillance, Epidemiology and End Results. Cancer incidence statistics, available at http://www.seer.cancer. gov.
105. Nienhaus, A., 2002. Brustkrebsrisiko von Friseuren durch die Anwendung von Haarfärbemitteln. Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin (BGVV), Berlin, Germany. Available at: http://www.bgvv.de.
106. Nohynek, G.J., 2003. Toxicokinetic-based safety assessment of hair dyes and their ingredients. Results presented at the Toxicology Forum, Brussels, Belgium, October 28, 2003.
107. Nomura A., Kolonel L.N., Yoshizawa C.N. Smoking, alcohol, occupation, and ahir dye use in cancers of the lower urinary tract. American Journal of Epidemiology. 130:1989;1159-1163.
108. NTP, 1978. US National Toxicology Program. Bioassay of 2, 4-Diaminoanisole Sulfate for Possible Carcinogenicity, NTP Report TR-84, available at http://ehis.niehs.nih.gov.
109. NTP, 1985a. US National Toxicology Program. Toxicology and Carcinogenesis Studies of HC Blue No. 1 in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Report T-271, available at http://ehis. niehs.nih.gov.
110. NTP, 1985b. US National Toxicology Program, Toxicology and Carcinogenesis Studies of 2-amino-5-nitrophenol in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Report T-334, available at http://ehis.niehs.nih.gov.
111. NTP, 1987. US National Toxicology Program, Toxicology and Carcinogenesis Studies of HC Red No. 3 in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Report T-281, available at http://ehis.niehs.nih.gov.
112. 1 Mice (Gavage Studies), NTP Report T-403, available at http://ehis.niehs.nih.gov.
113. Office of Environmental Health Assessment, 2002. Proposition 65. California Environmental Protection Agency. Available at http://www.oeha.ca.gov.
114. Ohno Y., Hamajima N., Mizuno S. Hair dye exposure and cancer - an epidemiological review. Current Medicine. 29(3):1982;459-471.
115. Ohno Y., Aoki K., Obata K., Morrison A.S. Case-control study on urinary bladder cancer in metropolitan Nagoya. Monographs of the National Cancer Institute. 69:1985;229-234.
116. Olausson, P., 2001. Centre for Epidemiology, National Board of Health and Welfare, Stockholm, Sweden, Personal Communication.
117. PAP, 2001. 1-Hydroxy-4-aminobenzene. Published and unpublished studies contained in the industry submission IV to the EU SCCNFP, 2001.
118. Parkinson A. Biotransformation of xenobiotics. Klassen C.D., Amdur A.O., Doull J. Casaretts and Doull's Toxicology - the Basic Science of Poisons, fifth edition. 1996;173-175 McGraw-Hill, New York, USA.
119. PTD, 2003. 1-Methyl-2,5-diaminobenzene. Unpublished studies contained in the 2003 Draft Submission II to the EU SCCNFP.
120. Prentice, D., 2002. Preclinical Safety Consultants, Ettingen, Switzerland, personal communication, April 2002.
121. Rhen L. Blasengeschwülste bei Anilinarbeitern. Archiv für klinische Chirurgie. 50:1895;588-600.
122. Rogier V. Safety assessment of cosmetic ingredients by the SCCNFP. general principles SÖFW-Journal. 129:2003;4-11.
123. Rojanapo W., Kupradinum P., Tepsuwan A., Chutimataewin S., Tanyakaset M. Carcinogenicity of an oxidation product of p-phenylenediamine. Carcinogenesis. 7:1986;12. 1997-2002.
124. Rutkowski J.V., Ferm V.H. Comparison of the teratogenic effects of the isomeric forms of aminophenol in the Syrian golden hamster. Toxicology Applied Pharmacology. 63:1982;204-269.
125. Rylander L., Axmon A., Toren K., Albin M. Reproductive outcome among female hairdressers. Journal of Occupational and Environmental Medicine. 59:2002;517-522.
126. Sardas S., Aygün N., Karakaya A.E. Genotoxicity studies on professional hair colorists exposed to oxidation hair dyes. Mutation Research. 394:1997;153-161.
127. Sasaki Y.F., Fujikawa K., Ishida K., Kawamura N., Nishikawa Y., Ohra S., Satoh M., Madarame H., Ueno S., Susa S., Matsusaka N., Tsuda S. The alkaline single cell gel electrophoresis assay with mouse multiple organs. results with 30 aromatic amines evaluated by IARC and US NTP Mutation Research. 440:1999;1-18.
128. SCC, 1991. Opinion of the EU Scientific Committee of Cosmetology concerning 1,4-diaminobenzene, Colipa No. A 7, 4 October 1991.
129. SCC, 1993. Opinion of the EU Scientific Committee on Cosmetics concerning resorcinol, adopted June 1993.
130. SCCNFP, 2000. The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers: Notes of Guidance for Testing of Cosmetic Ingredients for their Safety Evaluation, adopted 24 October 2000. Available at http://europa.eu.int/comm/food/fs/sc/sccp/outcome_en.html.
131. SCCNFP, 2001. The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers: Chemical ingredients identifies in cosmetic products classifies carcinogenic, mutagenic or toxic to reproduction according to the Chemicals Directive 67/548/eec. Adopted 25 September, 2001. Available at http://europa.eu.int/comm/food/fs/sc/sccp/outcome_en.html.
132. SCCNFP, 2002a. The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers: Opinion concerning p-phenylenediamine (Colipa A 7) adopted by the SCCNFP during the 19th plenary meeting, 27 February 2002. Available at http://europa.eu.int/comm/food/fs/sc/sccp/outcome_en.html.
133. SCCNFP, 2002b. The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers: Discussion paper on Assessment Strategies for Hair Dyes. February 27, 2002. Available at http://europa.eu.int/ comm/food/fs/sc/sccp/outcome_en.html.
134. Schaefer, H., Redelmeier, T.E., 1996. In vivo measurements of percutaneous penetration. In: Skin Barrier - Principles of Percutaneous Absorption Karger AG, Basel.
135. Schaumburg I., Olsen J. Birth weight and gestational age among children of Danish pharmacy assistants. Journal of Epidemiology and Community Health. 45(1):1991;49-51.
136. Schnuch A., Geier J., Uter P.J. National rates and regional differences in sensitisation to allergens of the standard series. Contact Dermatitis. 37:1997;200-209.
137. Selkirk J.K., Soward S.M. Abstracts from long-term cancer studies reported by the National Toxicology Program of the National Institute of Environmental Health Sciences from 1976 to 1982. Environmental Health Perspectives. 101(Suppl.):1993;295.
138. Sinuaes B., Paerez J., Bernal M.L., Saaenz M.A., Lanuza J., Bartholomae M. Urinary mutagenicity and N-acetylation phenotype in textile workers exposed to arylamines. Cancer Research. 52(18):1992;4885-4889.
139. Spengler J., Bracher M. Toxicological tests and health risk assessment of oxidative hair dye mixtures. Cosmetics and Toiletries. 105(2):1990;67-76.
140. Steinheider G., Neth R., Marquardt H. Evaluation of non-genotoxic and genotoxic factors modulating the frequency of micronucleated erythrocytes in the peripheral blood of mice. Cell Biology and Toxicology. 1(3):1985;197-211.
141. Stenbäck F.G., Rowland J.C., Russel A. Non-carcinogenicity of hair dyes. lifetime percutaneous applications in mice and rabbits Food and Cosmetic Toxicology. 15:1977;601-606.
142. Talaska G. Aromatic amines and human urinary bladder cancer. exposure sources and epidemiology Journal of Environmental Science and Health-Environmental Carcinogenesis and Ecotoxicology Review. C21(1):2003;13-29.
143. Thun M.J., Altekruse S.F., Namboodiri M.M., Calle E.E., Myers D.G., Heath C.W.R. Hair dye use and risk of fatal cancers in U.S. women. Journal of the National Cancer Institute. 86(3):1994;210-215.
144. Turanitz K., Kovac R., Tuschl H., Pavlicek E. Investigations on the effects of repeated hair dyeing on sister chromatid exchanges. Food and Chemical Toxicology. 21(6):1983;791-793.
145. Van de Sandt J.J.M., Rutten A.A.J.J.L., Van Ommen B. Species-specific cutaneous biotransformation of the pesticide propoxur during percutaneous absorption in vitro. Toxicology Applied Pharmacology. 123(1):1993;144-150.
146. Van Duren B.L. Carcinogenicity of hair dye components. Journal of Environmental Pathology and Toxicology. 3:1980;237-251.
147. Walter-Sack I., Lucknow V., Guserle R., Weber E. Untersuchungen der relativen Bioverfügbarkeit von Paracetamol nach Gabe von festen und flüssigen oralen Zubereitungen sowie rektalen Applikationsformen. Arzneimittelforschung. 39(1):1989;719-724.
148. Watanabe T., Kawata A., Koyanagi T. Mutagenicity of hair dyes. Journal of the Society of Cosmetical Chemistry Japan. 41(1):1980;20-25.
149. Watanabe T., Hirayama T., Fukui S. The mutagenic modulating effect of p-phenylenediamine on the oxidation of o- or m-phenylenediamine with hydrogen peroxide in the Salmonella test. Mutation Research. 245:1990;15-22.
150. Wolfram L.J., Maibach H.I. Percutaneous penetration of hair dyes. Archives of Dermatological Research. 277:1985;235-241.
151. Yabe K., Saito K., Murai T., Hara M.A., Watanabe H. An experimental rhabdomiolysis due to para-phenylenediamine contained in hair dyes. Research in Practical Forensic Medicin. 34:1991;109-115.
152. Yagi H., El Hendi A.M., Diab A., Elshikh A.A. Paraphenylenediamine induced optic atrophy following hair dye poisoning. Human and Experimental Toxicology. 15:1996;617-618.
153. Yajima N., Kurata Y., Sawai T., Takeshita Y. Comparative studies in induction of micronuclei by three genetically recombinant and urinary human erythropoeitins. Mutagenesis. 8(3):1993;237-241.
154. Yakugo Jiho Co Quasi-drug Registration Requirements in Japan. first ed. 1999;Tokyo, Japan.